Pharmaceuticals News and Research

RSS

Domainex has core intellectual property rights granted for Europe

Domainex Ltd (Domainex), an innovative biopharmaceutical company, today announced the grant of European Patent No.1442134 for its Combinatorial Domain Hunting (CDH) Technology.

From Domainex 14 Sep 2008

Schering-Plough launches Bridion (sugammadex) in Europe

Schering-Plough Corporation has announced that the European launch of Bridion (sugammadex) injection has begun with its introduction this week in Sweden, and that the product is expected to be available soon in the United Kingdom and Germany, with several other European markets to follow by the end of the year and in early 2009.

10 Sep 2008

Domainex, has core intellectual property rights granted for Europe

Domainex Ltd (Domainex) today announced the grant of European Patent No.1442134 for its Combinatorial Domain Hunting (CDH) Technology.

From Domainex 10 Sep 2008

The Hill examines Presidential candidates' positions on prescription drug issues

The Hill on Tuesday examined how Democratic presidential nominee Sen. Barack Obama (Ill.) and Republican presidential nominee Sen. John McCain (Ariz.) are perceived by the drug and biotech industries.

10 Sep 2008

Broad coalition of industry, not-for-profit groups push for passage of health IT legislation

The Health IT Now! Coalition on Tuesday will release a joint letter to House and Senate members urging them to redouble efforts to pass legislation for the creation of a nationwide electronic health records system, CongressDaily reports.

10 Sep 2008

GlaxoSmithKline and Cellzome announce major strategic alliance

Cellzome Inc. and GlaxoSmithKline have announced the signing of a worldwide strategic alliance to discover, develop and market novel kinase-targeted therapeutics to treat inflammatory diseases.

10 Sep 2008

New drug hope for cystic fibrosis patients

A science conference in the UK has heard some good news which offers hope to cystic fibrosis (CF) patients worldwide.

10 Sep 2008

Pfizer to withdraw global marketing applications for Dalbavancin to conduct a new trial

Pfizer Inc today announced it will globally withdraw all dalbavancin marketing applications for the treatment of complicated skin and skin structure infections in adults, including the U.S. new drug application (NDA) and the European marketing authorization application (MAA).

9 Sep 2008

New nanotechnology paints for hospitals could kill superbugs

New nanotechnology paints for walls, ceilings, and surfaces could be used to kill hospital superbugs when fluorescent lights are switched on, scientists heard today (Wednesday 10 September 2008) at the Society for General Microbiology's Autumn meeting being held this week at Trinity College, Dublin.

9 Sep 2008

New drug hope for cystic fibrosis patients

A new drug therapy may represent a tremendous step forward in the treatment of some 70,000 cystic fibrosis (CF) patients worldwide, Dr David Sheppard from the University of Bristol told an audience at the BA Festival of Science in Liverpool today [9 September].

9 Sep 2008

Supreme Court to consider whether to bar liability lawsuits against pharmaceutical companies

The U.S. Supreme Court in November will consider whether to shield the makers of prescription and over-the-counter drugs from liability lawsuits, the Los Angeles Times reports.

9 Sep 2008

FDA posts names of prescription drugs being investigated for potential safety problems

FDA officials on Friday said the agency will begin publishing quarterly a list of drugs being investigated for potential safety risks, the Washington Post reports.

9 Sep 2008

Antibiotics still being over-prescribed by GPs

Antibiotics are still being over-prescribed by GPs in contravention of guidelines, potentially contributing to antibiotic-resistant "superbugs", research launched at the British Pharmaceutical Conference (BPC) in Manchester has shown.

8 Sep 2008

Egg secretions from a worm may be useful in gene therapy

Egg secretions from a worm that causes a deadly human disease may prove useful in gene therapy, according to research presented at the British Pharmaceutical Conference (BPC) in Manchester.

8 Sep 2008

Pharmacists reduce hospital visits for patients with chronic obstructive pulmonary disease

Patients with chronic obstructive pulmonary disease (COPD) experience 55% fewer hospital admissions and 50% less visits to accident and emergency departments when clinical pharmacists intervene in their care, research launched at the British Pharmaceutical Conference (BPC) in Manchester has shown.

8 Sep 2008

New coating for urinary catheters reduce infection risk

A new coating for urinary catheters could reduce the risk of infection, according to research presented at the British Pharmaceutical Conference (BPC) in Manchester.

8 Sep 2008

Vaginal rings provide new HIV protection for women

Vaginal rings, similar to those used for contraception and hormone replacement therapy, could protect women from sexually-transmitted HIV, according to research presented at the British Pharmaceutical Conference (BPC) in Manchester.

8 Sep 2008

Salix commences patent infringement litigation against Novel Laboratories

Salix Pharmaceuticals, Ltd. has announced that Salix Pharmaceuticals, Inc. has filed a lawsuit in the United States District Court for the District of New Jersey against Novel Laboratories, Inc. for infringement of the patent protecting OSMOPREP (sodium phosphate monobasic monohydrate, USP and sodium phosphate dibasic anhydrous, USP) Tablets.

8 Sep 2008

Orexo and Boehringer Ingelheim extend collaboration

Orexo AB, the Swedish pharmaceutical company and Boehringer Ingelheim, the international pharmaceutical company headquartered in Ingelheim, Germany, have extended their existing three year research collaboration for a further 12 months from November 2008.

8 Sep 2008

60% of women use herbal products during pregnancy

Almost 60% of women use at least one herbal product during pregnancy, research launched at the British Pharmaceutical Conference (BPC) in Manchester has revealed.

7 Sep 2008